It was also reported that DNMT3A mutations were associated with adverse outcomes among patients with FLT3 mutations (48); moreover, the presence of two concomitant DNMT3A mutations was associated with an independent adverse prognostic effect on OS in patients with AML (49). The gene discussed is FLT3; the disease is acute myeloid leukemia.